Oculis Holding AG Ordinary shares

Price & Volume

Stats

52W Range	$10.79-$23.08
Market Cap	$858.7M
Shares Short	50,650

Financials

Revenue (12 Mos)	$686,000
Revenue Growth (YoY)	-98.4%
Gross Profit (12 Mos)	-$51.3M
Diluted EPS	-$2.62

News

Yahoo Finance • last year

Oculis Reports Q3 2023 Financial Results and Provides Company Update

Yahoo Finance • last year

Oculis to Present at Upcoming November Investor Conferences

Yahoo Finance • last year

Oculis to Present a Late-Breaking Abstract at the American Academy of Ophthalmology 2023 Annual Meeting on the Positive Stage 1 Results from Phase 3 DIAMOND Trial for Diabetic Macular Edema

Yahoo Finance • 2 years ago

Positive Phase 3 Stage 1 DIAMOND Trial Results of OCS-01 in Diabetic Macular Edema Presented at 23rd EURETINA Congress

About

CEO	Dr. Riad Sherif M.B.A., M.D.
Address	Bahnhofstrasse 20, Zug, Switzerland, 6300
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	49